What is the fair value of Amphastar P (NASDAQ-AMPH) stock?

The current fair value estimate for Amphastar P (NASDAQ-AMPH) is $32.72. This implies an estimated upside of 34.6% versus the current market price.

Is Amphastar P (NASDAQ-AMPH) undervalued or overvalued?

Based on the current fair value estimate, the stock appears undervalued, with estimated upside of 34.6% versus the current market price.

What is the analyst price target for NASDAQ-AMPH stock?

The available analyst price target for Amphastar P (NASDAQ-AMPH) is $22.50. The analyst target implies estimated downside of 7.5%.

How is the financial health of Amphastar P?

The current financial health read for Amphastar P (NASDAQ-AMPH) is Great. This should be reviewed alongside valuation, profitability, debt and cash-flow quality metrics.

When is Amphastar P's next earnings date?

The next earnings date currently listed for Amphastar P (NASDAQ-AMPH) is November 9, 2026.

Does Amphastar P (NASDAQ-AMPH) pay dividends?

The latest available data indicates no current dividend yield for Amphastar P (NASDAQ-AMPH).

What is the P/E ratio for Amphastar P (NASDAQ-AMPH)?

The current P/E ratio listed for Amphastar P (NASDAQ-AMPH) is 13.2x. Use it together with growth, margins and sector comparisons rather than as a standalone valuation signal.

What is the market capitalization of Amphastar P?

The current market capitalization listed for Amphastar P is 1.035 B.

What is the enterprise value of Amphastar P?

The current enterprise value listed for Amphastar P is 1.433 B. Enterprise value can provide a broader valuation view than market capitalization alone because it also considers net debt.

What is the ticker symbol for Amphastar P?

The ticker symbol for Amphastar P is NASDAQ-AMPH, and the stock is listed on NASDAQ.

Where is Amphastar P (NASDAQ-AMPH) listed?

Amphastar P (NASDAQ-AMPH) is listed on NASDAQ.

What is the debt-to-total-capital ratio for Amphastar P?

The current debt-to-total-capital ratio listed for Amphastar P is 39.8%, which helps investors evaluate the company’s financing structure and leverage profile.

What is the free float for Amphastar P?

The free float listed for Amphastar P is 73.6%. Free float helps investors understand how much of the share base is available for public trading.

Amphastar P (AMPH) Fair Value & Stock Analysis

Amphastar P (AMPH)

Amphastar Pharmaceuticals, Inc. is a biopharmaceutical company focused on generic and proprietary injectable, inhalation, and intranasal medicines. Through its common stock listed on NASDAQ under the symbol AMPH, the company serves markets in the United States, China, and France. Its product portfolio includes treatments used in emergency care, respiratory conditions, diabetes-related hypoglycemia, opioid overdose, anticoagulation, and other hospital and procedural settings. Amphastar also supplies active pharmaceutical ingredient products, including recombinant human insulin and porcine insulin API. Founded in 1996 and based in Rancho Cucamonga, California, the company operates within the healthcare sector and pharmaceuticals industry.

Stock Summary Fair Value Profitability & Growth Quality & Risk Events & Dividends Market Outlook FAQ

Jump directly to the stock analysis sections supported by the latest available data.

Data update note: Fair value and stock analysis metrics are updated after regular market sessions when new data becomes available.

Ticker	Fair Value	Fair Value Upside/Downside	Fair Value Rating	Analyst Price Target	Analyst Target Upside/Downside	Analyst Target Rating	Overall Financial Health	Dividend Yield	Next Earnings Date	P/E Ratio	Price-to-Book Ratio	Price-to-Sales Ratio	Market Cap	Enterprise Value	Total Debt / Total Capital	Free Float / Shares Outstanding	Altman Z-Score	Free Cash Flow / Net Income
NASDAQ-AMPH	$32.72	34.6% Upside	Undervalued	$22.50	-7.5% Downside	Fair	Great	0.0%	November 9, 2026	13.2x	1.3x	1.4x	1.035 B	1.433 B	39.8%	73.6%	3.0	194.7%